Real-World Results: How to Lose Weight with Orlistat and Wegovy Patients seeking medical weight loss solutions can now choose between two proven medications: Orlistat and Wegovy, each offering distinct approaches to weight management
Vandael D, Gounko NV (2019) Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimers disease and stress disorders
Supplements glutathione that decreases as aging to give your skin vitality
Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials
Figure 1 3 The impact of AITD on pregnancy Numerous studies have shown that AITD increases the risk of adverse pregnancy outcomes
#ObesityMedicine #WeightHealth #GLP1 #HealthcareInnovation #Longevity To view or add a comment, sign in Exciting news for obesity and metabolic health management
